Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database

Objective: Based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database, we analyzed the signals of potential adverse events (AEs) of orlistat in the real world to provide a reference for its safe clinical use. Methods: The FAERS database and OpenVigil 2.1 were used...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Jinfeng Zhu, Mianda Hu, Yingshi Liang, Mingjun Zhong, Zilin Chen, Zhenjie Wang, Yujia Yang, Ziyi Luo, Wenqi Zeng, Jiahui Li, Yikuan Du, Yi Liu, Chun Yang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-07-01
Sarja:	Heliyon
Aiheet:	Orlistat Adverse events FAERS Pharmacovigilance
Linkit:	http://www.sciencedirect.com/science/article/pii/S2405844024108687
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!